Your time to act is NOW: Breaking barriers in T2D care

Speaker: John Buse (USA)

 

The content for empagliflozin contained in this virtual session is intended for delegates from countries regulated by the European Medicines Agency (EMA), and does not include healthcare professionals in the UK or Ireland. Prescribing information may vary depending on local approval in each country inside and outside of Europe. Therefore, before prescribing any product, always refer to local materials such as the prescribing information and/or the Summary of Product Characteristics.